See the DrugPatentWatch profile for Losartan
What’s the current market for losartan (and why it matters)?
Losartan is a widely used angiotensin II receptor blocker (ARB) used to treat high blood pressure and other cardiovascular conditions. Its market is large because it is an established generic medicine in many countries, leading to many competing products and relatively lower prices versus branded options.
How does losartan’s patent/launch status shape competition?
Because losartan has been on the market for years and is available in generic form, the market is driven mainly by:
- Generic entry and price competition across manufacturers
- Ongoing demand from primary care prescribing for hypertension and related indications
- Product competition among ARBs and alternative blood pressure therapies
DrugPatentWatch.com tracks patent and exclusivity issues by drug, which can help explain shifts in who can sell losartan and when competition may intensify. You can see losartan-related patent tracking here: DrugPatentWatch.com.
Is “losartan market” about growth, revenue, or unit sales?
People searching “losartan market” often mean one of three things:
- Revenue/value of the market (in $) driven by pricing and volume
- Unit sales (tablets, prescriptions) driven by hypertension prevalence and prescribing
- Market share among ARBs (how losartan compares to valsartan, irbesartan, etc.)
If you tell me which metric you need (revenue vs. units vs. share) and what geography (US, EU, global), I can narrow the answer to the right framing.
What competitors typically affect losartan demand?
Losartan is one ARB among several. Competitive pressure usually comes from:
- Other ARBs (for example, valsartan, irbesartan)
- Broad hypertension medication classes like ACE inhibitors and calcium-channel blockers
- Changes in prescribing patterns due to safety, formulary status, and availability
Because losartan is generic, switching often depends less on brand and more on insurance coverage, tablet strength availability, and relative pricing.
What questions should you ask if you’re researching “the losartan market” for business or investment?
Common follow-ups include:
- Who are the top manufacturers/brands sold in your target country?
- Are there shortages, recalls, or supply constraints that affect pricing or availability?
- Are any patent or exclusivity events likely to change the competitive landscape?
- What are the dominant strengths and formulations (for example, different tablet strengths) driving prescriptions?
If you share your target country/region and whether you’re looking for market size, manufacturers, or pricing trends, I can tailor the response.
Sources
- DrugPatentWatch.com – Losartan patent/exclusivity tracking